Jean-Jacques Bienaim
2019
Compensation breakdown
| Non-Equity Incentive Plan | $2,323,200 |
|---|---|
| Option Awards | $3,220,218 |
| Salary | $1,200,385 |
| Stock Awards | $11,581,044 |
| Other | $81,009 |
| Total | $18,405,856 |
Bienaim received $11.6M in stock awards, accounting for 63% of the total pay in 2019.
Bienaim also received $2.3M in non-equity incentive plan, $3.2M in option awards, $1.2M in salary and $81K in other compensation.
Rankings
In 2019, Jean-Jacques Bienaim's compensation ranked 203rd out of 13,971 executives tracked by ExecPay. In other words, Bienaim earned more than 98.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 203 out of 13,971 | 99th |
Division Manufacturing | 72 out of 5,692 | 99th |
Major group Chemicals And Allied Products | 20 out of 2,189 | 99th |
Industry group Drugs | 16 out of 1,875 | 99th |
Industry Pharmaceutical Preparations | 15 out of 1,387 | 99th |
Pay ratio
| Jean-Jacques Bienaim's Pay | $18,405,856 |
|---|---|
| Median Employee's Pay | $190,917 |
| Pay Ratio | 96to 1 |
In 2019, the annual total compensation of Jean-Jacques Bienaim was $18,405,856.
The annual total compensation of the median employee at BioMarin Pharmaceutical was $190,917.
The ratio of Jean-Jacques Bienaim's pay to the pay of median employee was therefore 96 to one.
Bienaim's colleagues
We found five more compensation records of executives who worked with Jean-Jacques Bienaim at BioMarin Pharmaceutical in 2019.
2019
Henry Fuchs
BioMarin Pharmaceutical
President, Worldwide R&D
2019
Robert Baffi
BioMarin Pharmaceutical
President, Global Manufacturing amp; Technical Operations
2019
Jeff Ajer
BioMarin Pharmaceutical
Executive Vice President, Chief Commercial Officer
2019
Daniel Spiegelman
BioMarin Pharmaceutical
Chief Financial Officer
2019
Brian Mueller
BioMarin Pharmaceutical
Chief Financial Officer
News
April 12, 2022
April 13, 2021
April 14, 2020
April 23, 2019